325 related articles for article (PubMed ID: 35078116)
21. Health-related quality of life in pediatric patients with partial onset seizures or primary generalized tonic-clonic seizures receiving adjunctive perampanel.
Trigg A; Brohan E; Cocks K; Jones A; Tahami Monfared AA; Chabot I; Meier G; Campbell R; Li H; Ngo LY
Epilepsy Behav; 2021 May; 118():107938. PubMed ID: 33839450
[TBL] [Abstract][Full Text] [Related]
22. A post hoc analysis of the long-term safety and efficacy of perampanel in Asian patients with epilepsy.
Inoue Y; Kaneko S; Hsieh PF; Meshram C; Lee SA; Aziz ZA; Nabangchang C; Dash A
Epilepsia; 2019 Mar; 60 Suppl 1():60-67. PubMed ID: 30869167
[TBL] [Abstract][Full Text] [Related]
23. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial.
French JA; Krauss GL; Wechsler RT; Wang XF; DiVentura B; Brandt C; Trinka E; O'Brien TJ; Laurenza A; Patten A; Bibbiani F
Neurology; 2015 Sep; 85(11):950-7. PubMed ID: 26296511
[TBL] [Abstract][Full Text] [Related]
24. Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal-onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post hoc analysis of the open-label Study 342 (FREEDOM).
Husni RE; Ngo LY; Senokuchi H; Patten A; Hiramatsu H; Watanabe K; Yamamoto T
Epilepsia Open; 2022 Mar; 7(1):59-66. PubMed ID: 34657389
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of perampanel in generalized and focal to bilateral tonic-clonic seizures: A comparative study of Asian and non-Asian populations.
Nishida T; Lee SK; Wu T; Tiamkao S; Dash A
Epilepsia; 2019 Mar; 60 Suppl 1():47-59. PubMed ID: 30869168
[TBL] [Abstract][Full Text] [Related]
26. Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307.
Krauss GL; Perucca E; Ben-Menachem E; Kwan P; Shih JJ; Squillacote D; Yang H; Gee M; Zhu J; Laurenza A
Epilepsia; 2013 Jan; 54(1):126-34. PubMed ID: 22905878
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of perampanel as monotherapy for focal seizures: Experience from open-label extension studies.
Kwan P; Mintzer S; Laurenza A; Patten A; Cartwright K
Epilepsy Behav Case Rep; 2018; 9():1-5. PubMed ID: 29707476
[TBL] [Abstract][Full Text] [Related]
28. Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice.
Alonso-Singer P; Aguilar-Amat Prior MJ; Oliva-Navarro J; Massot-Tarrús A; Giráldez BG; Bermejo P; DeToledo-Heras M; Aledo-Serrano Á; Martínez-Cayuelas E; Tirado-Requero P; Velázquez-Fragua R; López-Sobrino G; Ojeda J
Epilepsy Behav; 2022 Sep; 134():108836. PubMed ID: 35870432
[TBL] [Abstract][Full Text] [Related]
29. Efficacy, safety, and tolerability of perampanel in Asian and non-Asian patients with epilepsy.
Tsai JJ; Ikeda A; Hong SB; Likasitwattanakul S; Dash A
Epilepsia; 2019 Mar; 60 Suppl 1():37-46. PubMed ID: 30869165
[TBL] [Abstract][Full Text] [Related]
30. Long-term tolerability, safety and efficacy of adjunctive perampanel in the open-label, dose-ascending Study 231 and extension Study 233 in Japanese patients with epilepsy.
Usui N; Akamatsu N; Nakasato N; Ohnishi A; Kaneko S; Hiramatsu H; Saeki K; Miyagishi H; Inoue Y
Seizure; 2018 Nov; 62():26-32. PubMed ID: 30267941
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study.
Rosenfeld W; Conry J; Lagae L; Rozentals G; Yang H; Fain R; Williams B; Kumar D; Zhu J; Laurenza A
Eur J Paediatr Neurol; 2015 Jul; 19(4):435-45. PubMed ID: 25823975
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of perampanel as early add-on therapy in Chinese patients with focal-onset seizures: a multicenter, open-label, single-arm study.
Gao L; Lu Q; Wang Z; Yue W; Wang G; Shao X; Guo Y; Yi Y; Hong Z; Jiang Y; Xiao B; Cui G; Gao F; Hu J; Liang J; Zhang M; Wang Y
Front Neurol; 2023; 14():1236046. PubMed ID: 37712083
[TBL] [Abstract][Full Text] [Related]
33. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
34. Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study.
Nishida T; Lee SK; Inoue Y; Saeki K; Ishikawa K; Kaneko S
Acta Neurol Scand; 2018 Apr; 137(4):392-399. PubMed ID: 29250772
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of perampanel monotherapy in patients with focal-onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open-label Study 342 (FREEDOM Study).
Yamamoto T; Lim SC; Ninomiya H; Kubota Y; Shin WC; Kim DW; Shin DJ; Hoshida T; Iida K; Ochiai T; Matsunaga R; Higashiyama H; Hiramatsu H; Kim JH
Epilepsia Open; 2020 Jun; 5(2):274-284. PubMed ID: 32524053
[TBL] [Abstract][Full Text] [Related]
36. Perampanel monotherapy for the treatment of epilepsy: Clinical trial and real-world evidence.
Yamamoto T; Gil-Nagel A; Wheless JW; Kim JH; Wechsler RT
Epilepsy Behav; 2022 Nov; 136():108885. PubMed ID: 36150304
[TBL] [Abstract][Full Text] [Related]
37. Perampanel: as adjunctive therapy in patients with partial-onset seizures.
Plosker GL
CNS Drugs; 2012 Dec; 26(12):1085-96. PubMed ID: 23179642
[TBL] [Abstract][Full Text] [Related]
38. Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307.
Krauss GL; Perucca E; Ben-Menachem E; Kwan P; Shih JJ; Clément JF; Wang X; Bagul M; Gee M; Zhu J; Squillacote D
Epilepsia; 2014 Jul; 55(7):1058-68. PubMed ID: 24867391
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies.
Steinhoff BJ; Ben-Menachem E; Ryvlin P; Shorvon S; Kramer L; Satlin A; Squillacote D; Yang H; Zhu J; Laurenza A
Epilepsia; 2013 Aug; 54(8):1481-9. PubMed ID: 23663001
[TBL] [Abstract][Full Text] [Related]
40. Long-term safety and efficacy of brivaracetam in adults with focal seizures: Results from an open-label, multinational, follow-up trial.
Arnold S; Laloyaux C; Schulz AL; Elmoufti S; Yates S; Fakhoury T
Epilepsy Res; 2020 Oct; 166():106404. PubMed ID: 32731118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
